-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114. Hemoglobinopathies, Excluding Thalassemia—Clinical: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, anticoagulant drugs, Biological, Coronaviruses, sickle cell disease, Diseases, Non-Biological, sickle cell trait, Elderly, Therapies, Adverse Events, Genetic Disorders, Pediatric, red blood cells, Biological Processes, Hemoglobinopathies, Young Adult, Cell Lineage, Study Population, Clinically relevant, imaging, pharmacology, Quality Improvement , transfusion
Monday, December 7, 2020: 7:00 AM-3:30 PM

Banu Aygun, MD1,2, George A. Tomlinson, PhD, BSc, MSc3*, Patrick T. McGann, MD4,5, Leon Tshilolo, MD PhD6*, Thomas N. Williams, MD PhD7*, Peter Olupot-Olupot, MD PhD8*, Brigida Santos, MD9*, Susan E. Stuber, MA10*, Adam Lane, PhD11*, Teresa Latham, MA10* and Russell E. Ware, MD, PhD5,12

1Pediatric Hematology Oncology and Stem Cell Transplantation, Cohen Children's Medical Center, New Hyde Park, NY
2Cohen Children's Medical Center of New York, New Hyde Park, NY
3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
4Cincinnati Children's Hospital Medical Center, Division of Hematology, Cincinnati, OH
5Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
6Centre Hospitalier Monkole, Kinshasa, Congo (The Democratic Republic of the)
7KEMRI-Wellcome Trust Programme, Kilifi, Kenya
8Mbale Clinical Research Institute, Mbale, Uganda
9Hospital Pediatrico David Bernardino, Luanda, Angola
10Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
11Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
12Cincinnati Children's Hospital Medical Center, Children's Hospital Medical Center, Cincinnati, OH

Brigida Santos, MD1*, Maria Nakafeero2*, Adam Lane, PhD3*, Leon Tshilolo, MD PhD4*, Thomas N. Williams, MD PhD5*, Peter Olupot-Olupot, MD PhD6*, Janet Adams7*, Banu Aygun, MD8, Susan E. Stuber, MA9*, George A. Tomlinson, PhD, BSc, MSc10*, Teresa Latham, MA9*, Patrick T. McGann, MD7,11 and Russell E. Ware, MD, PhD11,12

1Hospital Pediatrico David Bernardino, Luanda, Angola
2Global Health Uganda, Kampala, UGA
3Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Centre Hospitalier Monkole, Kinshasa, Congo (The Democratic Republic of the)
5KEMRI-Wellcome Trust Programme, Kilifi, Kenya
6Mbale Clinical Research Institute, Mbale, Uganda
7Cincinnati Children's Hospital Medical Center, Division of Hematology, Cincinnati, OH
8Pediatric Hematology Oncology and Stem Cell Transplantation, Cohen Children's Medical Center, New Hyde Park, NY
9Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
10Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
11Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
12Cincinnati Children's Hospital Medical Center, Children's Hospital Medical Center, Cincinnati, OH

Renee Cheng, MD1, Andrew Srisuwananukorn, MD2*, Jin Han3*, Michel Gowhari, DO4, Franklin Njoku, MD5*, Faiz Ahmed Hussain, MD6*, Robert E. Molokie, MD7,8, Victor R. Gordeuk, MD5 and Santosh L. Saraf, MD5,9

1Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL
2Mount Sinai Health System, New York, NY
3Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
4Division of Hematology/Oncology, University of Illinois at Chicago College of Medicine, Chicago, IL
5Department of Medicine, University of Illinois at Chicago, Chicago, IL
6Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
7Jesse Brown VA Medical Center, Chicago, IL
8Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
9Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

Kenneth W. Wood, PhD1*, James Geib, BS1*, Eric Wu, PhD1*, Jason Berlin, MS1*, Irena Webster, MPH, MA1*, Kenneth I. Ataga, MD2, Jo Howard, MBBChir, MRCP, FRCPath3, Jeremie H. Estepp, MD4, Marilyn J. Telen, MD5 and Julie Brevard, MPH1*

1Forma Therapeutics, Inc., Watertown, MA
2University of Tennessee Health Science Center at Memphis, Memphis, TN
3Guy's and St. Thomas' Hospital, London, United Kingdom
4Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5Duke Univ. Med. Ctr., Durham, NC

Emmanuela E. Ambrose, MD1,2, Luke R. Smart, MD3,4,5, Primrose Songoro, RN6*, Idd Shabani, MD7,8*, Protas Komba, MD1*, Mwesige Charles, BScHLS9*, Thad A. Howard, MS4*, Susan E. Stuber, MA4*, Adam Lane, PhD10*, Teresa Latham, MA4*, Abel Nkono Makubi, PhD, MD, MSc11* and Russell E. Ware, MD, PhD3,4

1Department of Paediatrics and Child Health, Bugando Medical Centre, Mwanza, Tanzania, United Republic of
2Department of Paediatrics and Child Health, Catholic University of Health & Allied Sciences, Mwanza, Tanzania, United Republic of
3Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Division of Hematology/Oncology, University of Cincinnati, Cincinnati, OH
6Department of Paediatrics, Bugando Medical Centre, Mwanza, Tanzania, United Republic of
7Department of Pathology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania, United Republic of
8Department of Pathology, Bugando Medical Centre, Mwanza, Tanzania, United Republic of
9Department of Laboratory Services, Bugando Medical Centre, Mwanza, Tanzania, United Republic of
10Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
11Bugando Medical Centre, Mwanza, Tanzania, United Republic of

Najibah Aliyu Galadanci, MBBS, MPH1, Maira Sohail, MPH2*, Oluwasegun Philip Akinyelure, MBBS, MPH2*, Akinyemi I. Ojesina, MBBS, PhD2* and Julie Kanter, MD3,4

1School of Public Health/Epidemiology, University of Alabama at Birmingham, Birmingham, AL
2School of Public health/Epidemiology, University of Alabama at Birmingham, Birmingham, AL
3Hematology/Oncology, Comprehensive Sickle Cell Center, University of Alabama at Birmingham, Birmingham, AL
4Division of Hematology-Oncology, University of Alabama-Birmingham, Birmingham, AL

Olubusola Oluwole, MD, MS1, Amma owusu-Ansah, MD, MSc2*, Seyed Mehdi Nouraie, MD, PhD3* and Enrico M Novelli, M.D., M.S.4

1University of Washingon, Seattle, WA
2Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
3Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
4Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA

Matthew M. Heeney, MD1, David C. Rees, MD2*, Mariane de Montalembert, MD, PhD3*, Isaac Odame, MD4,5, R. Clark Brown, MD, PhD6, Yasser Wali, MD7*, Thu Thuy Nguyen8*, Du Lam, MD9*, Raquel Merino Herranz10* and Julie Kanter, MD11

1Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston
2Department of Paediatric Haematology, King's College Hospital, London, United Kingdom
3Hôpital Universitaire Necker-Enfants Malades, Paris, France
4The Hospital for Sick Children (SickKids), Toronto, Canada
5University of Toronto, Toronto, Canada
6Children's Healthcare of Atlanta, Atlanta, GA
7Sultan Qaboos University Hospital, Muscat, Na, Oman
8Novartis Pharma S.A.S., Rueil-Malmaison, France
9Novartis Pharmaceuticals Co., East Hanover, NJ
10Novartis Pharmaceuticals Co., Basel, Switzerland
11Division of Hematology-Oncology, University of Alabama-Birmingham, Birmingham, AL

Ahmar Urooj Zaidi, MD1, Thokozeni Lipato, MD2*, Ofelia A. Alvarez, MD3, Alexander Lonshteyn, PhD4*, Derek Weycker, PhD4*, Nhat Pham4*, Thomas E Delea, MSIA4*, Irene Agodoa, MD5*, Ze Cong, PhD5* and Nirmish Shah, MD6

1Wayne State University/Children's Hospital of Michigan/Detroit Medical Center, Detroit Medical Center, Detroit, MI
2Virginia Commonwealth University, Richmond, VA
3Univ. of Miami School of Med., Miami, FL
4Policy Analysis Inc. (PAI), Brookline, MA
5Global Blood Therapeutics, South San Francisco, CA
6Division of Hematology, Duke University School of Medicine, Durham, NC

Charity I Oyedeji, MD1,2, Carl Pieper, PhD2,3*, Katherine Hall, PhD2,4,5*, Miriam Morey, PhD2,4,5*, Heather Whitson, MD, MHS2,4* and John J. Strouse, MD, PhD1,6

1Department of Medicine, Division of Hematology, Duke University School of Medicine, Durham, NC
2Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC
3Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC
4Department of Medicine, Division of Geriatrics, Duke University Medical Center, Durham, NC
5Geriatric Research, Education and Clinical Center, Veterans Affairs Medical Center, Durham, NC
6Pediatric Hematology/Oncology, Duke University School of Medicine, Durham, NC

Prasanth Lingamaneni1*, Krishna Moturi, MD2*, Sheeba Ba Aqeel, MD3*, Shristi Upadhyay Banskota, MD1*, Binav Baral, MD1* and Maryam Zia4

1John H Stroger Hospital of Cook County, Chicago, IL
2John H. Stroger Hospital of Cook County, chicago, IL
3John Stroger Hospital of Cook County, Chicago, IL
4Division of Hematology/Oncology, John H Stroger Jr. Hospital of Cook County, Chicago, IL

Kenneth I. Ataga, MD1, Santosh L. Saraf, MD2, Vimal K. Derebail, MD3*, Claire C. Sharpe4*, Adlette Inati, MD, FAAP5, Jeffrey D. Lebensburger, DO6, Laurie DeBonnett, MD7*, Yifan Zhang, PhD7* and Pablo Bartolucci, MD, PhD8*

1UTHSC Center for Sickle Cell Disease, Memphis, TN
2Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
3University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC
4Renal Sciences, Department of Inflammation Biology, King’s College London, London, United Kingdom
5Lebanese American University, School of Medicine, Beirut and Division of Pediatric Hematology and Oncology, Nini Hospital, Tripoli, Lebanon
6Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
7Novartis Pharmaceuticals Corporation, East Hanover, NJ
8Service de Médecine Interne, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris 12, Créteil, France

Jennifer G. Davila, MD1, Sarah H. O'Brien, MD2 and Joseph R Stanek, MS3*

1The Children's Hospital At Montefiore-Aecom, Bronx, NY
2Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, Nationwide Children's Hospital, Columbus, OH
3Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH

Sharmila Raghunandan, DO, MPH1*, Derrick L Goubeaux, DO2, Christine R Hollenkamp, APRN3*, Rae M Blaylark, CHW3* and Stephen C Nelson, MD4*

1Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA
2Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN
3Children's Minnesota, Minneapolis, MN
4Children's Hospitals and Clinics of Minnesota, Minneapolis, MN

Yagahira E. Castro-Sesquen, Ph.D.1*, Santosh L. Saraf, MD2, Victor R. Gordeuk, MD3, Sergei Nekhai, PhD4 and Marina Jerebtsova, PhD5

1Department of Microbiology, Howard University, Washington DC, DC
2Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
3Department of Medicine, University of Illinois at Chicago, Chicago, IL
4Center for Sickle Cell Disease and Department of Medicine, Howard University, Washington, DC
5Department of Microbiology, Howard University, Washington, DC

Vignesh Chidambaram1*, Jennifer Jones, MD2, Parvez Lokhandwala, MD3*, Sophie M. Lanzkron, MD, MHS2, Rosalyn Stewart, MBA., MD, MS4* and Lydia H. Pecker, MD2

1Johns Hopkins Bloomberg School of Public Health, LITTLE ROCK, AR
2Department of Medicine, Division of Hematology, Johns Hopkins Medicine, Baltimore, MD
3Department of Transfusion Medicine, Johns Hopkins University, Baltimore, MD
4Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD

Sarah Sewaralthahab, MBBS, MPH and Hedy Smith, MD, PhD

Medstar Washington Hospital Center, Washington, DC

Nirmish Shah, MD1, Ahmar Urooj Zaidi, MD2, Michael U. Callaghan, MD3, Darla Liles, MD4, Clarissa E. Johnson, MD5* and Laura M De Castro, MD, MHSc6

1Duke University Health System, Durham, NC
2Wayne State University/Children's Hospital of Michigan/Detroit Medical Center, Detroit Medical Center, Detroit, MI
3Department of Pediatrics, Central Michigan University, Detroit, MI
4Division of Hematology–Oncology, Vidant Medical Center/East Carolina University, Greenville, NC
5Cook Children's Medical Center, Fort Worth, TX
6Comprehensive Sickle Cell Center, University of Pittsburgh Medical Center, Pittsburgh, PA

Avani Singh, MD1, Conner Olsen, MD1*, Xu Zhang, PhD2* and Robert E. Molokie, MD3,4

1Department of Internal Medicine, University of Illinois at Chicago, Chicago, IL
2Department of Medicine, University of Illinois at Chicago, Chicago, IL
3Jesse Brown VA Medical Center, Chicago, IL
4Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL

Victor R. Gordeuk, MD1, Barbara Kroner, PhD2*, Norma Pugh, PhD2*, Jane S. Hankins, MD, MS3, Abdullah Kutlar, MD4, Allison A. King, MD, MPH, PhD5, Nirmish Shah, MD6, Julie Kanter, MD7, Jeffrey Glassberg, MD8* and Marsha Treadwell, PhD9*

1Department of Medicine, University of Illinois at Chicago, Chicago, IL
2RTI International, Research Triangle Park, NC
3Associate Member, Director of the Sickle Cell Program, St. Jude Children's Research Hospital, Memphis, TN
4Center for Blood Disorders, Augusta University, Augusta, GA
5Washington University in St. Louis, Clayton, MO
6Division of Hematology, Duke University School of Medicine, Durham, NC
7Director, Adult Sickle Cell Program, Comprehensive Sickle Cell Center,, Birmingham, AL
8Icahn School of Medicine at Mount Sinai, New York City, NY
9Children's Hospital and Research Center, Oakland, Oakland, CA

*signifies non-member of ASH